Skip to main content

Brittney Griner Sentenced To Over 9 Years Hard Labour For Cannabis Possession In Russia

The WNBA star, arrested at the airport in February with less than a gram of cannabis oil, is bringing global attention to the issue of continued cannabis criminalization

Just one week before Russia invaded Ukraine, Brittney Griner landed in Russia with the expectation of playing her next off-season. That hope was dashed almost as soon as she landed. Officials found a few vape cartridges containing less than a gram of cannabis oil in her luggage. For this “crime” she was promptly arrested. Her subsequent detention and now conviction and sentencing has made global headlines.

Griner is a medical cannabis user, despite the fact that it is still banned by the WNBA and has been certified medically as such in her home state of Arizona since 2013. She also testified in court that she had packed the vape cartridges by accident before she left the US and did not realize they were in her luggage.

A Global Call for Decriminalization

As a local Arizona man buys 6,500 Mercury tickets to support Griner and the WNBA held a moment of silence for her on Sunday, both the US State Department and the Biden White House are working to obtain her release. This, despite the fact that cannabis use is still federally illegal in the United States, where thousands of people remain in jail because of their own cannabis use and possession.

While it appears that she was deliberately targeted for political purposes that have nothing to do with cannabis reform by the Russian government, and her case was certainly mishandled, even under Russian law, it is clear that Griner’s plight has just added fuel to the fire for the cannabis legalization cause globally.

In Germany, where recreational legalization is now slated to occur sometime in the next 24 months, the German press has covered the case with interest. It is clear, at least aus Deutschland that this is a global example of what happens when patients are unjustly prosecuted, although of course, German patients still face criminal charges when caught with “undocumented” cannabis.

What Happens Next?

It is very likely, given the increasing din domestically, that the White House will be on the hot seat until Griner is returned home. However, this incident is, tragically, not likely to move either the Senate or the White House to implement cannabis reform any time soon – even after the U.S. midterm elections which occur in the fall.

As such, Griner becomes “just” the next, if globally high-profile victim of a Drug War which has still not ended, no matter how much there appears to be a light at the end of the tunnel in several countries.

Minister Of Justice In Germany’s Largest State Expresses Support For Cannabis Legalization

Benjamin Limbach is the new Minister of Justice of North Rhine-Westphalia and has stated that he considers the legalization of cannabis to be a German “right”

In an encouraging development for the recreational cannabis discussion, Benjamin Limbach, the Green Party-affiliated Minister of Justice and member of the state cabinet as of June, has now publicly backed recreational reform. According to Limbach, he will help implement any law the Bundestag passes in Germany’s largest state.

This is encouraging news, particularly given the battles on the ground so far in the state also referred to as “NRW,” where the city of Dusseldorf was forced to reverse its ban on CBD just last year after losing in court.

Will There Be NIMBY Issues in Germany?

While politicians of all stripes are beginning to recognize that backing the legalization of cannabis is a winning issue, there is also no doubt that reform will also, like it has in other places, instigate more local backlashes to continue to ban the legal sales of adult-use cannabis. There may also be local bans on cultivation and manufacturing.

While cannabis legalization is increasingly popular with the public as a whole, there are still many who believe that this is not a positive development.

So far, of course, this issue has not been an issue in Germany, but that is because nothing has become concrete. In neighbouring Holland, local communities protested local cannabis cultivation farms after they had been selected in a national bid.

National Law, Local Regulations

One of the more interesting questions that has so far been left unanswered is whether local jurisdictions and municipalities will be able to ban either local production or sales once recreational reform becomes the law of the land. In California, for example, despite having a legitimate legal market since 1996 and a recreational one since 2016, there are still counties and municipalities that have banned dispensaries outright.

Given the highly emotional response to cannabis use that is still present everywhere, this is likely to become a political issue post-legalization. In the meantime, continue to expect high-ranking politicians who are in the ruling government coalition to publicly support the advance of the Traffic Light Coalition policy. For the very first time aus Deutschland at least, supporting recreational reform has become not only a political game-changer but an issue politicians will back to bolster their careers.

UK’s Top Contender For Prime Minister Criticized For U-Turn On Cannabis Reform

In an increasingly bitter and close race, Tory rival for the top political job, Rishi Sunak has criticized Liz Truss for her flip-flop on cannabis reform

The current political battle in the UK to replace Boris Johnson has gotten increasingly nasty if not out of touch with the issues that most people are now facing. The top two rivals for the Prime Minister’s office, have been slugging away at each other’s policies for weeks now.

Given this, it was inevitable that the issue of cannabis reform would surface, in some form.

Now Rishi Sunak, dubbed “Dishy Rishi” by his detractors, who would become not only the first non-white Prime Minister but the first practicing Hindu to hold the office, has gone there. Specifically, he has attacked Liz Truss, his opponent, for once supporting cannabis reform – when she was a student at Oxford and the one-time president of the Oxford Liberal Democrats.

Interestingly, Sunak, who also spent time in California while attending Stanford University to obtain an MBA degree, is not taking a stand on cannabis reform, even of the medical kind. His criticism is that Truss is a politician who will flip flop to gain political advantage and holds no fixed beliefs. She currently opposes cannabis reform as a member of the Tory party.

It is the kind of campaign not seen (yet) in the United States or Germany – two countries where the issue of federal cannabis reform is now looming. It is also a sign of how far even medical cannabis reform still has to go in the UK – forget full legalization.

Where Cannabis Reform Now Stands in Britain

The UK is now suffering from high inflation, post-Brexit woes, and a political discussion that has been warped beyond recognition because of the same. As literally millions of Britons are suffering from energy costs that have increased dramatically this year plus food and medicine shortages, the Tory leadership battle has focussed on esoteric issues that have little to do with the major problems now faced by the majority of the country.

In the meantime, the government is at a literal standstill under the lame duck tenancy of Boris Johnson, who was forced out by members of his own party after one too many scandals earlier this summer.

The issue of cannabis reform is, as a result, unlikely to become a political force on a national level in this kind of environment. Indeed, it has stagnated all over the country, even in places like the Channel Islands where local support had gelled for proceeding.

It is unlikely that the UK will be able to hold out forever, no matter who wins the current leadership contest. Indeed, it will be a potent political issue in the next national election, due to be held in the next several years.

Until then, however, look for the same old, tired excuses for failing to enact more comprehensive policies from the Tory party as cannabis patients continue to suffer and people are convicted of criminal charges even for small amounts of cannabis. There are currently an estimated 17,000 “legal” cannabis patients in Britain.

Leading Public Health Expert Calls For Slovenia To Embrace Cannabis Reform

Slovenia is one of the most beautiful places on earth. Located in central Europe, Slovenia is bordered by Austria, Hungary, Croatia, and to the southwest by Italy. With so much going on in Europe on the cannabis industry and policy fronts, Slovenia may not be the first place that comes to mind when it comes to the emerging cannabis industry. However, the nation is home to a growing cannabis community and reform efforts there recently received a huge boost from a leading public health expert.

Cf. Dušan Nolimal, Ph.D. recently published an extensive op-ed via one of Slovenia’s largest media outlets, Delo, in which he called on lawmakers to pass a number of cannabis reform measures. Dr. Nolimal also urged lawmakers to take meaningful steps to create a policy and regulatory framework in Slovenia that is conducive to helping the nation become an international cannabis hub. It’s a very thoughtful and thorough op-ed that everyone should read. For more information regarding Dr. Nolimal, I suggest that you check out his bio at this link here.

The Economic Benefits Of Legalization

Slovenia is home to roughly two million people, with the major industries in the country being pharmaceuticals, automotive parts, electrical appliances, and food processing. The nation’s GDP ranks 29th in Europe and 82nd globally. Slovenia, like all countries, would greatly benefit from embracing the emerging cannabis industry and the economic boost that it creates, including boosts to local economies, job creation, and tax revenue generation. That is in addition to the government savings that would instantly be achieved by Slovenia no longer enforcing failed cannabis prohibition policies.

A large sector of Slovenia’s economy is based on food. According to World Atlas, “About 704 companies were registered in the sector in 2015 employing about 12,658 people. The income generated from the sector amounted to $2.27 billion. The sector is among the third largest employers in processing activities alongside the production of electrical appliances and metal working.”

Slovenia’s chemical and pharmaceutical sector employs roughly 26,000 people, with 72% of the sector’s sales coming from the export market. The food sector and the pharmaceutical sector may not seem like a logical combination to non-cannabis observers, however, people involved in the emerging cannabis industry will be quick to recognize the enormous demand for medical-grade cannabis edibles, and that the demand is only going to increase for the foreseeable future.

According to global data company Technavio, the global cannabis-infused edible product market is anticipated to grow by USD 25.27 billion from 2020 to 2025, and the sector will increase in size by roughly 21.74% annually. Slovenia is well-positioned to gain a sizable share of that specific sector, and it’s just one of the many examples of how a legalized and embraced cannabis industry in Slovenia can help bring jobs and economic benefits to the country. Other examples include, but are certainly not limited to: cannabis research, industry intellectual property development, ancillary industry equipment manufacturing, and raw material processing.

The Opportunity Costs Of Delaying

A major point that is highlighted in Dr. Nolimal’s op-ed is that time is not frozen while lawmakers in Slovenia drag their feet on reforming the nation’s cannabis laws. Countries across Europe are reforming their laws, creating regulations, and ramping up their cannabis industry efforts, not the least of which is Germany. And all the while people are consuming cannabis for medical and adult use in Slovenia every day, albeit not legally.

The longer that Slovenia waits, the farther behind it will be compared to other countries that embraced cannabis reform and the emerging cannabis industry earlier. It may also result in Slovenia having less input on what its future cannabis laws and public health strategies contain, as pointed out by Dr. Nolimal in his op-ed.

“If the Ministry of Health delays until cannabis is approved by other European countries, foreign commercial entities will be able to have a very significant influence on the determination of national legislation regarding cannabis in our country.” Dr. Nolimal stated in his op-ed piece.

“This could be a major problem, as the commercial interest in cannabis may be diametrically opposed to the interests of the public health profession, which should already be advocating a zero-tolerance policy for young and vulnerable groups and moderate use and risk reduction for adults.” Dr. Nolimal went on to state.

Cannabis reform is spreading across Europe, and once Germany launches its legalized adult-use industry it will no doubt result in a tidal wave of reform within the European continent as well as elsewhere on the planet. It would be very wise for Slovenia’s lawmakers to heed Dr. Nolimal’s advice and reform the nation’s cannabis laws as soon as possible, and build a regulated cannabis industry that harnesses the skills, talent, and resources that are already in Slovenia, and with it, create once-in-a-lifetime economic opportunities for Slovenia’s citizens.

Are Banking Concerns Really Delaying Cannabis Reform In Belize?

Lawmakers in Belize previously passed the ‘Cannabis and Industrial Hemp Control and Licensing Bill 2022.’ The measure passed both chambers of Belize’s Parliament and was set to become law.

However, cannabis prohibitionists, particularly church leaders, were able to successfully stall the passage of the bill and divert it into Belize’s referendum process.

A vote was initially set for later this year on September 4th. That vote is now being delayed, with no future vote date set from what I can tell. The reasoning for the delay? ‘Concerns’ about banking. Per Caribbean National Weekly:

The Belize government has confirmed that concerns raised by the banking community have led to the Cannabis and Industrial Hemp Control and Licensing Bill 2022 being temporarily shelved despite going through all the states in Parliament.

Home Affairs and New Growth Industries Minister, Kareem Musa, was asked by reporters to comment on his reluctance to admit that banking sector concerns would present a roadblock to the bill.

“Cannabis legalization is taking place all across the Caribbean. Like the rest of the Caribbean, Belize always has correspondent banking concerns. As you recall with the offshore sector, we had to make certain regulations and adjustments to comply with the European Union so that we were not blacklisted.”

To many cannabis industry and policy observers around the globe, the excuse offered up for delaying the referendum vote seems to be a stretch. After all, many countries engage in the emerging legal cannabis industry, including nations in the European Union.

There seems to be a lot of rhetoric being tossed around on this topic, but not a lot of real-world examples of it actually happening. Hopefully cannabis reform can get back on track in Belize sooner rather than later.

Cannabis Purchasing Habits Continue To Shift In British Columbia

British Columbia has long been home to a vibrant and robust cannabis community. People have flocked to British Columbia for cannabis tourism purposes for several decades now.

International cannabis industry and policy observers have kept a close eye on Canada, and British Columbia specifically, to gauge consumer and patient cannabis purchasing habits in the post-legalization era.

Consumers and patients have more well-established, unregulated cannabis sourcing options in British Columbia than in most other parts of the world. It was unclear leading up to the launch of adult-use legalization what percentage of people making purchases may transition to making purchases via regulated outlets.

There’s new data out regarding purchases made in 2021, and it appears that the number of people making regulated purchases is increasing. Per Global News:

More British Columbians are using cannabis since legalization, but appear to be doing so in a responsible way and getting it more often from licensed retail stores, according to a recent survey.

The 2021 B.C. Cannabis Use Survey asked just under 25,000 British Columbians about their cannabis use and found 32 per cent of adults aged 19 and older reported using cannabis at least once in the past year, an increase from 28 per cent prior to legalization. Around four per cent of people said they tried cannabis for the first time since legalization in 2018.

“Like many provinces and territories, cannabis use has gradually become more prevalent in B.C., with nonsmoking methods of use increasing in popularity,” the report states.

One thing that the report seemed to spend a lot of focus on involved whether people were consuming cannabis ‘responsibly’ or not. That is obviously a subjective measurement.

Ultimately, the report seemed to measure this by a combination of things, including DUI data, reported frequency of use by consumers, and various other data points.

The data seems to back up what many of us already know – that cannabis legalization works and the doomsday predictions by prohibitionists leading up to national legalization in Canada have proven to be unfounded.

Cannabis May Be A “Useful Treatment Strategy” For Fibromyalgia Patients

Fibromyalgia is a serious problem across the globe, affecting people of all ages. It is estimated that as many as one out of every twenty people on earth suffer from the condition to some degree.

According to Mayo Clinic, “Fibromyalgia is a disorder characterized by widespread musculoskeletal pain accompanied by fatigue, sleep, memory and mood issues.”

Unfortunately, there is currently no known cure for fibromyalgia, however, researchers in Canada have found evidence that medical cannabis can be an effective treatment for some patients. Below is more information about it via a news release from NORML:

Montreal, Canada: Cannabis products are associated with symptom relief among fibromyalgia (FM) patients, according to data published in the journal Arthritis Care & Research.

Canadian researchers assessed the efficacy of medical cannabis products (flower or extracts) over a one-year period in a cohort of patients with FM. Investigators assessed patients’ levels of pain intensity, sleep quality, and depression/anxiety every three months. All of the subjects enrolled in the study were qualified to use medical cannabis products by their general practitioner.

Consistent with other studies, researchers reported an association between the consumption of medical cannabis and improvements in subjects’ sleep, depression/anxiety, and pain – with the greatest reduction in pain intensity (a mean decrease of 1.7 points on a zero to 10 scale) occurring within the first six-months of treatment.

Authors reported: “Our current findings are consistent with observations of pain relief, improved sleep, and alleviation of symptoms of anxiety and depression in other studies among patients with chronic pain using medical cannabis. Although preliminary, our findings suggest that improvements in negative affect and sleep might represent potential mechanisms of action underlying pain reductions among FM patients who are using medical cannabis.”

They concluded, “Medical cannabis may present a useful treatment strategy for patients with FM in light of an effect on the triad of symptoms of pain, negative affect, and sleep disturbances.”

Survey data reports that fibromyalgia patients frequently consume cannabis for therapeutic purposes. A recent review of the relevant literature concluded, “[T]he use of cannabinoids and cannabis carries limited side effects in the treatment of FM, and they can also improve some common and debilitating symptoms associated with FM, thus making them an adequate potential treatment option, when other treatment lines have been exhausted.”

Full text of the study, “Predictors of pain reduction among fibromyalgia patients using medical cannabis: A long-term prospective cohort trial,” appears in Arthritis Care & Research. Additional information on cannabinoids and FM is available from NORML.

Finding The Right Balance Among European Cannabis Industry Regulatory Models

The entire European continent seems to be trending towards legalization for the most part, and for the small group of nations that are still dragging their feet, the writing is on the wall. It’s only a matter of time before they get on the right side of history because every day that goes by is a day that other nations inch closer to beating them to the cannabis revenue punch.

Cannabis policy is not as straightforward as many seem to think. Simply stating that cannabis should be legal in general terms is one thing. Crafting national cannabis policies and regulations is a completely different matter and requires much more thought and planning, and that is just at a national level.

Just as Europe is a continent made up of many nations, so too will it be a continent made up of many different approaches to cannabis policy and regulation. Below is just a small sampling of cannabis policy facets that lawmakers and regulators need to consider when drafting measures:

  • Home Cultivation – plant limits, canopy size limits, public view restrictions, etc.
  • Commercial Cultivation – zoning, infrastructure needs, licensing
  • Commercial Sales – allowed or continued to be prohibited?
  • Imports/Exports – if yes, what regulations are involved?
  • Social Use – can people consume in clubs, and if so, under what conditions?

Those are just a handful of things that need to be taken into consideration, and even those have several sub-facets as well. It can be a daunting task, especially when considering that Europe is composed of dozens of countries, each with its own identity, culture, and approach to governing.

Right now there are already several different cannabis industry models in existence in Europe. Malta passed an adult use legalization measure late last year, although its model is based on home cultivation and non-profit entities from which consumers can source their cannabis.

Low-THC cannabis, or ‘cannabis light,’ has been sold all over Switzerland since 2017, and a pilot adult-use cannabis industry program for higher THC varieties is launching this summer in the country as well. Pilot programs are also in operation in Denmark, and hopefully soon, the Netherlands.

All nations need to learn from each other and collaborate to enact continental-level rules and regulations to help ensure that public safety concerns are addressed in a way that still allows the industry to reach its full potential (within reason).

Education is key, and with that in mind, we recommend that people check out a timely report from Augur Associates. The report is titled, ‘Which models for cannabis adults use regulation in Europe? – findings, objectives and proposals for legalisation.’

Augur Associates is a Paris-based consultancy agency dedicated to the sustainable and cutting-edge cannabis and hemp industry. In addition to their latest report, they have also published a number of other reports dealing with the emerging cannabis industry and shifting political landscape.

Their latest publication is a robust 271-page report in its complete version, with the additional option of downloading the summary version. Both options are free at Augur and Associates’ website (previously linked to in this article). The report is also coupled with a number of insightful recommendations from the publishers for lawmakers and regulators to consider.

All eyes are on Europe for the foreseeable future, and information of this value does not come along often, especially for free. Check out the latest report from Augur Associates because the more timely information that you know, the better suited you are to make informed decisions. It could mean the difference between you crushing it in the evolving international cannabis industry or fizzling out not long after you get started.

Cannabis Prohibition Is An Inhumane Governing Policy Everywhere That It Exists

Various arguments and talking points are offered up by cannabis prohibitions to ‘justify’ keeping cannabis prohibition policies in place, however, none of them outweigh the harms of cannabis prohibition. With news surfacing this week regarding WNBA star Brittney Griner’s lengthy prison sentence in Russia related to alleged possession of a cannabis vape cartridge, many cannabis prohibition talking points are being offered up to ‘justify’ what has happened to Griner. None of those talking points are valid and certainly do not in any manner outweigh the inhumane treatment that Griner has endured and will continue to endure until this matter is finally and sufficiently remedied.

When someone makes the claim that ‘Brittney Griner should have known that she was breaking the law,’ they are basing their stance on the inhumane premise that for whatever reason it’s OK to punish people for cannabis-only acts. In Griner’s case, she was allegedly in possession of one semi-used vape pen cartridge from what I understand and is now going to serve the better part of a decade in prison in Russia pending some type of successful, meaningful help from the United States government. What Griner is enduring right now is clearly cruel and unusual punishment, and it’s shameful that cannabis prohibitionists are using the case to further their own harmful agendas.

The Brittney Griner Case Summarized

For those that have not followed the case, WNBA legend and Olympic champion Brittney Griner was first arrested in Russia back in February, roughly one week prior to Russia invading Ukraine. News of the arrest did not surface until weeks later.

Initially, the United States government was very quiet about how it would approach the case, with people in Griner’s network (fellow players, family members, friends, etc.) making public comments that they were urged to not speak out about the case. Eventually, the Biden administration ramped up efforts to intervene in Griner’s case and applied a similar status (wrongfully detained) to Griner’s case that it already had applied to other cases in which U.S. citizens were subjected to Russia’s criminal justice system.

Ultimately, Griner pled guilty to the charges, however, that does not actually mean that she was guilty of what she was being accused of. For starters, Griner stated in court that, “I’d like to plead guilty, your honor. But there was no intent. I didn’t want to break the law,” Griner said in English, which was then translated to Russian for the court proceedings, according to Reuters. “I’d like to give my testimony later. I need time to prepare.”

Legal scholars pointed out that a guilty plea in Russia is a sound legal strategy being that roughly 99% of cases result in a guilty verdict in Russia and that pleading guilty is necessary in order to start the prisoner swap process, which is likely the only way that Griner will ever make it back to United States soil.

“Traditionally, the best defense is to admit your guilt and hope you get a lesser sentence,” Willam Pomeranz, the acting director of the Wilson Center’s Kennan Institute in Washington and an expert on Russian law, told ESPN. “There’s not a lot of examples of people raising strong defenses and getting acquitted.”

Brittney Griner Is A Victim Of Prohibition, Politics, And Systemic Inequity

As expected, many people are weighing in on Griner’s 9-year prison sentence and aspects of her case now that the guilty verdict was officially rendered. Some cannabis community members are pointing to Griner’s case and then pivoting to talking points regarding Joe Biden’s unwillingness to free cannabis prisoners in the U.S. Others are pointing to a recent arrest of an NBA player in Texas and asking the logical question of why isn’t that case receiving more attention?

While all of those questions are valid, in many cases the points being made by cannabis supporters miss the main point that prohibition is wrong, it is always wrong, and prohibition is to blame in Griner’s case, Iman Shumpert’s case, as well as every other case in which someone is penalized due to cannabis-only offenses.

Griner’s case is getting significant attention because of additional compounding factors involved, not the least of which are the timing of her arrest leading up to Russia’s invasion of Ukraine, as well as the pay inequity issues in Griner’s home country that had her going to Russia in the first place. It’s widely reported that Griner was in Russia at the time of her arrest, however, her being a perennial basketball superstar in Russia’s professional women’s basketball league and being compensated over 4 times as much in Russia compared to in the United States is far less reported.

Brittney Griner was traveling to Russia for work and assuming that it was actually her vape cartridge(s), she was taking her meds with her on her work trip. Yes, those meds are illegal in Russia, but that doesn’t make Russia’s policy right. Unfortunately, Griner is now a political prisoner in Russia, and the only realistic way that she will ever be released is via a prisoner swap. The Biden administration has reportedly been in negotiations with Russia, however, the negotiations have failed to yield results so far.

The Biden administration needs to do everything that it can to free Brittney Griner, as well as do everything that it can to free cannabis prisoners in the United States, and those two things are not mutually exclusive and are simultaneously important. Furthermore, everyone everywhere needs to fight for sensible cannabis policies so that no one is ever locked up for cannabis in the first place.